ZA981034B - Formulation of stabilized cationic transfection agent(s)/nucleic acid particles - Google Patents

Formulation of stabilized cationic transfection agent(s)/nucleic acid particles

Info

Publication number
ZA981034B
ZA981034B ZA981034A ZA981034A ZA981034B ZA 981034 B ZA981034 B ZA 981034B ZA 981034 A ZA981034 A ZA 981034A ZA 981034 A ZA981034 A ZA 981034A ZA 981034 B ZA981034 B ZA 981034B
Authority
ZA
South Africa
Prior art keywords
nucleic acid
transfection agent
formulation
acid particles
cationic transfection
Prior art date
Application number
ZA981034A
Other languages
English (en)
Inventor
Joel Crouzet
Bruno Pitard
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9503492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA981034(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA981034B publication Critical patent/ZA981034B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA981034A 1997-02-10 1998-02-09 Formulation of stabilized cationic transfection agent(s)/nucleic acid particles ZA981034B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (fr) 1997-02-10 1997-02-10 Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees

Publications (1)

Publication Number Publication Date
ZA981034B true ZA981034B (en) 1998-08-11

Family

ID=9503492

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981034A ZA981034B (en) 1997-02-10 1998-02-09 Formulation of stabilized cationic transfection agent(s)/nucleic acid particles

Country Status (20)

Country Link
EP (1) EP1007097B1 (pt)
JP (1) JP2001511171A (pt)
KR (1) KR20000070914A (pt)
AT (1) ATE206932T1 (pt)
AU (1) AU737720B2 (pt)
BR (1) BR9807563A (pt)
CA (1) CA2278665A1 (pt)
CZ (1) CZ282199A3 (pt)
DE (1) DE69802102T2 (pt)
DK (1) DK1007097T3 (pt)
ES (1) ES2166146T3 (pt)
FR (1) FR2759298B1 (pt)
GR (1) GR3036919T3 (pt)
HU (1) HUP0001720A3 (pt)
IL (1) IL130765A0 (pt)
NO (1) NO993825D0 (pt)
PT (1) PT1007097E (pt)
SK (1) SK282685B6 (pt)
WO (1) WO1998034648A1 (pt)
ZA (1) ZA981034B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6359054B1 (en) * 1994-11-18 2002-03-19 Supratek Pharma Inc. Polynucleotide compositions for intramuscular administration
AU768542C (en) * 1998-04-08 2004-06-17 Celltech R & D Limited Lipids
DE69906977T2 (de) * 1998-07-20 2004-05-19 Protiva Biotherapeutics Inc., Burnaby In liposomen verkapselte nukleinsäurekomplexe
CA2401239A1 (en) * 2000-03-03 2001-09-13 Valentis, Inc. Improved poloxamer and poloxamine compositions for nucleic acid delivery
GB0009201D0 (en) * 2000-04-14 2000-05-31 Univ Nottingham Cationic polymer - Nucleic acid complexes and methods of making them
US20020091242A1 (en) 2000-10-11 2002-07-11 Michel Bessodes Acid-sensitive compounds, their preparation and uses
EP1337242B1 (en) * 2000-10-20 2011-03-30 Vical Incorporated Gene delivery formulations for treatment of ischemic conditions
EP1232758A1 (fr) * 2001-02-19 2002-08-21 Aventis Pasteur Polynucléotide formulé en vue d'un transfert intracellulaire amélioré
JP2007527431A (ja) 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
BRPI0608249A2 (pt) 2005-03-03 2009-12-08 Revance Therapeutics Inc formulação, método para aplicação tópica e kit para distribuição transdérmica de toxina botulìnica
JP4653242B1 (ja) * 2010-02-12 2011-03-16 ナノキャリア株式会社 粒子状医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1181937A3 (en) * 1994-08-09 2004-02-04 Cytrx Corporation Novel vaccine adjuvant and vaccine
WO1996030051A1 (en) * 1995-03-31 1996-10-03 Genetic Therapy, Inc. Use of surfactants for introducing genetic material into lung cells
US6120794A (en) * 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells

Also Published As

Publication number Publication date
FR2759298A1 (fr) 1998-08-14
IL130765A0 (en) 2001-01-28
DK1007097T3 (da) 2002-02-11
AU6298798A (en) 1998-08-26
JP2001511171A (ja) 2001-08-07
KR20000070914A (ko) 2000-11-25
WO1998034648A1 (fr) 1998-08-13
FR2759298B1 (fr) 1999-04-09
DE69802102D1 (de) 2001-11-22
EP1007097B1 (fr) 2001-10-17
ATE206932T1 (de) 2001-11-15
PT1007097E (pt) 2002-04-29
CZ282199A3 (cs) 1999-10-13
DE69802102T2 (de) 2002-03-14
BR9807563A (pt) 2000-02-01
CA2278665A1 (fr) 1998-08-13
SK282685B6 (sk) 2002-11-06
EP1007097A1 (fr) 2000-06-14
ES2166146T3 (es) 2002-04-01
HUP0001720A1 (hu) 2000-09-28
GR3036919T3 (en) 2002-01-31
SK108299A3 (en) 2000-05-16
AU737720B2 (en) 2001-08-30
HUP0001720A3 (en) 2001-10-29
NO993825L (no) 1999-08-09
NO993825D0 (no) 1999-08-09

Similar Documents

Publication Publication Date Title
ZA981034B (en) Formulation of stabilized cationic transfection agent(s)/nucleic acid particles
US6136294C1 (en) Amino acid stabilized medical aerosol formulation
EP0911039A3 (en) Drug-resin complexes stabilized by chelating agents
IL129547A (en) Pharmaceutical compositions comprising a macrolide and an acid
HK1042444A1 (zh) 藥用噴霧製劑
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
HK1028548A1 (en) Formulations for hydrophobic pharmaceutical agents
WO2000032186A3 (en) Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
MX9804848A (es) Emulsiones estables que comprenden un ingrediente liquido hidrofobico.
CA2194979A1 (en) Solid drug forms containing clathrates of steroid sex hormones
YU8701A (sh) Nova oralna kompozicija
SG48485A1 (en) Stabilization of non-halogenated 3-isothiazolones in aggressive systems
BR9811985A (pt) Dispositivo de dosagem
WO2002083891A3 (en) Nucleic acids for inhibiting hairless protein expression and methods of use thereof
PH11997055419B1 (en) Cleansing composition comprising color stabilizer(s) and surfactant(s)
WO1998023260A3 (en) Non-ionic surfactant vesicles as a delivery agent for nucleic acid
WO2001006963A3 (en) Orthopaedic bone cement mixing container
EP0891778A3 (en) Agents for the prevention and/or treatment of radiation-induced disorders
Gorshkov et al. Effects of Nitrogen-Containing Compounds on H sub 2 PtCl sub 6 Activity in Hydrosilication of Unsaturated Siloxane Rubbers
MX9706067A (es) Composiciones liquidas que contienen tensoactivos alquil poliglicosidos para la limpieza industrial e institucional.
MX9708160A (es) Composicion y aparato para la limpieza de superficies.
SI1007097T1 (en) Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
BG101703A (en) Antiparasitic medicamentous form and method for itsapplication
MX9708163A (es) Composicion y aparato para la limpieza de superficies.